GlaxoSmithKline

Glaxo's Asthma Drug Nucala Gets Fda Nod For Pediatric Use

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GlaxoSmithKline plc (GSK): Free Stock Analysis Report AstraZeneca PLC (AZN): Free...
Related topics: Asthma, Food And Drug Administration, Medical Research, Astrazeneca

Read More →

Using A Phosphine Oxide Catalyst To Make Nucleophilic Substitution Reactions Of Alcohols Greener

A team of researchers with the University of Nottingham, Jealott's Hill International Research Centre and the GlaxoSmithKline, Medicines Research Centre, has found a way to use a phosphine oxide catalyst to make nucleophilic substitution reactions...
Related topics: Medical Research

Read More →

Ionis (ions) Out-licenses Hepatitis B Virus Program To Glaxo

Ionis Pharmaceuticals, Inc. IONS announced that it has out-licensed its antisense medicine candidates for treating patients with chronic hepatitis B (CHB) virus infection to pharma giant GlaxoSmithKline plc GSK. Following positive phase II results,...
Related topics: Hepatitis, Hepatitis B, Virus, Virology

Read More →

Better Buy: Eli Lilly Vs. Glaxosmithkline

Eli Lilly (NYSE: LLY) and GlaxoSmithKline (NYSE: GSK) are undergoing transformations. Both big drugmakers have launched multiple new products to drive future growth while simultaneously dealing with sagging sales of older drugs.The companies'...

Read More →

Roche's Flu Medicine Xofluza Meets Goal In Study On Kids

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AstraZeneca PLC (AZN): Free Stock Analysis Report GlaxoSmithKline plc (GSK): Free...
Related topics: Flu, Influenza (Flu), Medical Research, Astrazeneca

Read More →

Glaxo Presents Encouraging Data On Endometrial Cancer Drug

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GlaxoSmithKline plc (GSK): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock...
Related topics: Endometrial Cancer, Cancer, Oncology, Medical Research, Pfizer

Read More →

Better Buy: Glaxosmithkline Vs. Eli Lilly

If you haven't looked at GlaxoSmithKline (NYSE: GSK) and Eli Lilly (NYSE: LLY) in several years, you probably wouldn't recognize them today. Eli Lilly recently spun off its animal health segment, and Glaxo's merging its consumer health business with...

Read More →

Merck's Keytruda Gets Fda Priority Review For Head/neck Cancer

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GlaxoSmithKline plc (GSK): Free Stock Analysis Report Merck & Co., Inc. (MRK): Get...
Related topics: Merck & Co, Food And Drug Administration, Cancer, Oncology, Medical Research

Read More →

Mylan's Generic Version Of Advair Diskus Wins Fda Approval

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GlaxoSmithKline plc (GSK): Free Stock Analysis Report Novartis AG (NVS): Get Free...
Related topics: Food And Drug Administration, Medical Research, Novartis

Read More →

How To Save $650 Million Without Really Trying

When GlaxoSmithKline (NYSE: GSK) dropped out of the bidding process for Pfizer's (NYSE: PFE) consumer healthcare division, it appeared that Pfizer's only option was to spin off the segment as a new company.Apparently GlaxoSmithKline ultimately had...
Related topics: Pfizer

Read More →

It's Ok To Make Money On Genetic Research

In July, 23andMe and pharmaceutical giant GlaxoSmithKline (GSK) announced a $300 million collaboration that will focus on research and development of new medicines and cures, using insights from human genetics as the basis for discovery. GSK will...
Related topics: Genetics, Medical Research

Read More →

Meet Pfizer And Glaxosmithkline’s New Joint Venture

GlaxoSmithKline shares bounced higher on Wednesday after the company announced a new joint venture with Pfizer. These two firms will create a premier global consumer health care company combining...
Related topics: Pfizer

Read More →

This Health Startup Lets You Monetize Your Dna

23andMe and other DNA testing companies make money by selling genetic data. LunaDNA wants to make you the one who benefits when your genes are worth something. When 23andMe made a $300 million deal with GlaxoSmithKline in July–so the...
Related topics: Startup, DNA, Genetics

Read More →

Pharma Giant Gsk Just Made A $5.1 Billion Bet On A Cancer Drugmaker (gsk, Tsro)

Pharma giant GlaxoSmithKline just acquired cancer drugmaker Tesaro for $5.1 billion in a bid to bulk up its cancer pipeline.
Related topics: Cancer, Oncology

Read More →

Glaxo (gsk) And J&j's Hiv Drug Juluca Gets Approval In Japan

GlaxoSmithKline plc GSK and partner Johnson & Johnson JNJ announced that the Ministry of Health, Labour and Welfare (MHLW) granted a marketing approval to Juluca for the maintenance treatment of HIV -1 infection in Japan.Juluca combines two...
Related topics: HIV, Virus, Marketing

Read More →

Continuing Shingrix Vaccine Shortage Challenging Physicians, Patients

GlaxoSmithKline has struggled to keep up with runaway demand for the vaccine, which has patients and physicians scrambling to find elusive supplies. Medscape Medical News
Related topics: Vaccines

Read More →

Glaxo's Nucala Suffers Regulatory Setback, Gets Crl For Copd

GlaxoSmithKline plc GSK announced that the FDA has issued a complete response letter (CRL) to its supplemental biologics license application (sBLA) for label expansion of its asthma drug, Nucala for a new indication — eosinophilic chronic...
Related topics: Chronic Obstructive Pulmonary Disease, Food And Drug Administration, Asthma

Read More →

Glaxo's Asthma Drug Gets Eu Nod For Pediatric Population

GlaxoSmithKline Plc. GSK announced that the European Commission has given a marketing approval to its asthma drug Nucala for treating pediatric patients. Following the regulatory body’s decision, Nucala (mepolizumab) is now available as an...
Related topics: Asthma, Marketing

Read More →

Astrazeneca's Bevespi Unimpressive In Phase Iii Copd Study

AstraZeneca AZN announced disappointing data from a phase IIIb study evaluating Bevespi Aerosphere for treating moderate to very severe chronic obstructive pulmonary disease (“COPD”). The study compared the drug to...
Related topics: Astrazeneca, Chronic Obstructive Pulmonary Disease, Medical Research

Read More →

Cashing In On Dna: Race On To Unlock Value In Genetic Data

How much is your DNA worth? As millions of people pay for home tests to check on ancestry or health risks, genetic data is becoming an increasingly valuable resource for drugmakers, triggering a race to create a DNA marketplace....
Related topics: DNA, Genetics

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.